Applied dna reports first quarter fiscal 2023 financial results

Stony brook, n.y.--(business wire)---- $apdn #lineardna--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in pcr-based dna technologies, today announced consolidated financial results for the first quarter of fiscal 2023, ended december 31, 2022.

APDN Ratings Summary

APDN Quant Ranking